4,253
Views
33
CrossRef citations to date
0
Altmetric
Reports

CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors

, , , , , , , , , , , , , , , , , , , & show all
Pages 436-453 | Received 29 Jun 2015, Accepted 06 Nov 2015, Published online: 28 Jan 2016

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.